Robert Bayer
 | This article has multiple issues. Please help improve it or discuss these issues on the talk page. (Learn how and when to remove these messages)
|
Robert Bayer is a US researcher of lobster nutrition, management, and pathology. Since 2018, he is serving as the chief science officer at Lobster Unlimited, a company that is creating value-added products from lobster processing waste byproducts.[1][2] From 1995 to 2018, he served as the executive director of Lobster Institute, University of Maine,[3][1]
Bayer is an alumnus of the University of Vermont, where he received his bachelor's and master's degree, and Michigan State University, where he received his doctoral degree.[4] He is also a professor emeritus of Animal and Veterinary Sciences at the University of Maine.[1] He holds several research patents, including one for gaffkemia vaccine[5] and another one for the application of lobster hemolymph to treat mammalian tissue lesions.[4][6]
References
- ^ a b c "Robert Bayer - School of Food and Agriculture - University of Maine". School of Food and Agriculture. Retrieved 2021-02-08.
- ^ "Lobster Unlimited". scratchpad. Retrieved 2021-02-08.
- ^ Daniels, Jeff (February 20, 2017). "Treating warts with a lobster's blood? This Maine researcher is out to prove it can be done". CNBC. Retrieved February 9, 2021.
- ^ a b "Robert C. Bayer – Maine Science Festival". Retrieved 2021-02-08.
- ^ US 4215108, Rittenburg, James H. & Bayer, Robert C., "Lobster gaffkemia vaccine", published 1980-07-29, assigned to Research Corp.
- ^ US 9078906, Bayer, Robert C., "Lobster hemolymph as a utility for treatment of mammalian tissue lesions", issued 2013-02-16
  | This article about a biologist from the United States is a stub. You can help Wikipedia by expanding it. |